Pregled po CROSBI profilu: Robert Šeparović (CROSBI Profil: 33431, MBZ: 355091, ORCID: 0000-0002-4002-2699)
Pronađeno 223 radova
-
1.Impact of COVID-19 pandemic on metastatic colorectal cancer outcomes // Annals of Oncology Abstract Book
Barcelona, Španjolska, 2023. str. 43-43 (poster, međunarodna recenzija, sažetak, stručni) -
2.IMPACT OF IMMUNOHISTOCHEMICAL CHARACTERISTICS OF TUMOR ON RESPONSE TO DUAL ANTI-HER2 BLOCKADE – DATA FROM REAL CLINICAL PRACTICE // Libri Oncologici
Zagreb, 2023. str. 68-69 (poster, domaća recenzija, sažetak, stručni) -
3.Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial // European Journal of Cancer, 184 (2023), 48-59 doi:10.1016/j.ejca.2023.02.002 (međunarodna recenzija, članak, znanstveni)
-
4.Impact of Body Composition on the Quality of Life of Premenopausal Patients with Early Stage Breast Cancer During Chemotherapy // Acta clinica Croatica, 61 (2022), 605-612 doi:10.20471/acc.2022.61.04.06 (međunarodna recenzija, članak, znanstveni)
-
5.Could initial radiological response be used to predict duration of first-line treatment in HER2 positive metastatic breast cancer? // 16th Central European Oncology Congress Book of abstract
Opatija, Hrvatska, 2022. str. 91-92 (poster, međunarodna recenzija, sažetak, znanstveni) -
6.Jetrena toksičnost povezana s inhibitorima kinaza ovisnih o ciklinima (CDK4/6I) - iskustvo jedne institucije // Liječnički vjesnik
Rovinj, Hrvatska, 2022. str. 74-75 (poster, recenziran, sažetak, stručni) -
7.Nuspojave sustavne kemobiološke terapije u liječenju proširenog HER2-pozitivnog raka dojke:rezultati iz stvarne kliničke prakse // Liječnički vjesnik
Rovinj, Hrvatska, 2022. str. 85-86 (poster, recenziran, sažetak, stručni) -
8.Incidence of hypokalemia during therapy with abirateron acetate - real clinical practice data // Libri Oncologici : Croatian Journal of Oncology
online, 2022. str. 55-55 (poster, međunarodna recenzija, sažetak, stručni) -
9.Nivolumab induced hypopituitarism – case report // Libri Oncologici : Croatian Journal of Oncology
online, 2022. str. 64-64 (poster, međunarodna recenzija, sažetak, stručni) -
10.Assessment of cutaneous toxcitiy in cancer patients treated with CDK 4/6 inhibitors and endocrine therapy according to patient-related outcomes at the University Hospital for tumors // Libri Oncologici : Croatian Journal of Oncology
Opatija, Hrvatska, 2022. str. 88-89 (poster, međunarodna recenzija, sažetak, stručni) -
11.Is quality of life (QoL) during chemotherapy affected by body composition? // Ananls of oncology ESMO ABSTRACT
Berlin, Njemačka, 2022. str. 228-228 doi:10.1016/j.annonc.2022.03.243 (poster, međunarodna recenzija, sažetak, stručni) -
12.Impact of local treatments on survival of patients with liver metastases from colorectal cancer (CRC) in real-life setting // Annals of Oncology Abstract Book
Barcelona, Španjolska, 2022. str. 319-320 doi:10.1016/j.annonc.2022.04.287 (poster, međunarodna recenzija, sažetak, znanstveni) -
13.Concordance of preoperative breast MRI finding with definitive postoperative pathology report, after neoadjuvant systemic treatment in patients with breast cancer // 2022 SABCS Abstracts and Disclosures
San Antonio (TX), Sjedinjene Američke Države, 2022. str. 392-394 (poster, međunarodna recenzija, sažetak, stručni) -
14.41P Comprehensive genomic profiling in the management of ovarian cancer: National results from Croatia // Annals of oncology
Valencia, Španjolska: Elsevier BV, 2022. str. S399-S399 doi:10.1016/j.annonc.2022.04.059 (poster, međunarodna recenzija, sažetak, stručni) -
15.The New-Onset of Intrathoracic Lymphadenopathy in Patients Previously Treated for Colorectal Carcinoma // Journal of Ultrasound in MedicineVolume 41: Official Proceedings of the AIUM Annual Integrative Ultrasound Meeting
San Diego (CA), Sjedinjene Američke Države, 2022. str. 143-143 doi:10.1002/jum.16028 (poster, međunarodna recenzija, sažetak, znanstveni) -
16.Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3) // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 144 (2022), 9-10; 295-305 doi:10.26800/lv-144-9-10-2 (međunarodna recenzija, pregledni rad, znanstveni)
-
17.Konjugati protutijela i lijeka u liječenju proširenog raka dojke // XXXI. ZNANSTVENI SASTANAK "BOLESTI DOJKE", HAZU / Zvonko Kusić, Josip Unušić (ur.).
Zagreb: Hrvatska akademija znanosti i umjetnosti (HAZU), 2022. str. 103-114 doi:10.21857/ygjwrcp1dy (predavanje, domaća recenzija, cjeloviti rad (in extenso), znanstveni) -
18.Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia // Journal of Personalized Medicine, 12 (2022), 7; 1176, 11 doi:10.3390/jpm12071176 (međunarodna recenzija, članak, znanstveni)
-
19.Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial // 2020 San Antonio Breast Cancer Virtual Symposium
San Antonio (TX), Sjedinjene Američke Države: American Association for Cancer Research (AACR), 2021. str. 03-03 doi:10.1158/1538-7445.sabcs20-pd3-03 (poster, međunarodna recenzija, sažetak, stručni) -
20.How does reinduction of first-line chemotherapy in patients with metastatic colorectal cancer impact outcomes? Experience from the University Hospital for Tumors, Zagreb, Croatia // Annals of Oncology Abstract Book of the ESMO 23rd World Congress on Gastrointestinal Cancer
online, 2021. str. 101-101 doi:10.1016/j.annonc.2021.05.071 (poster, međunarodna recenzija, sažetak, stručni) -
21.Smjernice za dijagnostiku i praćenje karcinoma glave i vrata // Liječnički vjesnik
Šibenik, Hrvatska, 2021. str. 13-15 (predavanje, recenziran, sažetak, stručni) -
22.Procjena umora u oboljelih od raka dojke liječenih na Klinici za tumore palbociklibom i antihormonskom terapijom prema upitniku o ishodu liječenja prijavljenom od strane bolesnik // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 143 (2021), Suppl 1
Šibenik, Hrvatska, 2021. str. 102-103 doi:10.26800/LV-143-supl1-3 (poster, recenziran, sažetak, stručni) -
23.Management of abemaciclib side effects in clinical practice – case report // 1st Croatian virtual congress of oncology pharmacy
online, 2021. str. 58-59 (poster, međunarodna recenzija, sažetak, stručni) -
24.Thrombocytopenia induced by immune checkpoint inhibitors in triple negative breast cancer patient – case report // Libri Oncologici : Croatian Journal of Oncology
online, 2021. str. 56-57 (poster, međunarodna recenzija, sažetak, stručni) -
25.Difference in Estimation of Side Effects of Chemotherapy between Physicians and Patients with Early-Stage Breast Cancer: The Use of Patient Reported Outcomes (PROs) in the Evaluation of Toxicity in Everyday Clinical Practice // Cancers, 13 (2021), 23; 5922, 7 doi:10.3390/cancers13235922 (međunarodna recenzija, članak, znanstveni)
-
26.Kako optimalno neo/adjuvantno liječiti trostruko negativni rak dojke // XXX. ZNANSTVENI SASTANAK "BOLESTI DOJKE", HAZU / ZVONKO KUSIĆ, JOSIP UNUŠIĆ (ur.).
Zagreb: Hrvatska akademija znanosti i umjetnosti (HAZU), 2021. str. 125-137 doi:10.21857/yk3jwhxor9 (predavanje, domaća recenzija, cjeloviti rad (in extenso), znanstveni) -
27.Immunity and cancer: role of tumor – infiltrating lymphocytes in triple negative breast cancer // Libri oncologici : Croatian journal of oncology, 49 (2021), 1; 20-28 doi:10.20471/LO.2021.49.01.03 (recenziran, pregledni rad, stručni)
-
28.Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice // Pathology oncology research, 27 (2021), 1609963, 8 doi:10.3389/pore.2021.1609963 (međunarodna recenzija, članak, znanstveni)
-
29.Neoadjuvant treatment for HER2 positive early breast cancer – differences between trastuzumab monotherapy and dual anti-HER2 blockade in our clinical practice // Libri oncologici:3th REGIONAL CONGRESS OF MEDICAL ONCOLOGY / Šeparović, Robert (ur.).
Zagreb, 2021. str. 59-60 (poster, međunarodna recenzija, sažetak, ostalo) -
30.Clinical value of androgen receptors in triple negative breast cancer // Libri oncologici: 3th REGIONAL CONGRESS OF MEDICAL ONCOLOGY / Šeparović, Robert (ur.).
Zagreb, 2021. str. 48-48 (poster, međunarodna recenzija, sažetak, ostalo) -
31.Cardiac safety of palbociclib in breast cancer patients with cardiac risk // Libri Oncologici: 3th REGIONAL CONGRESS OF MEDICAL ONCOLOGY / Šeparović, Robert (ur.).
Zagreb, 2021. str. 45-45 (poster, međunarodna recenzija, sažetak, ostalo) -
32.Body composition of breast cancer patients treated with adjuvant chemotherapy and its influence on quality of life // Libri Ocologici: 3th REGIONAL CONGRESS OF MEDICAL ONCOLOGY / Šeparović, Robert (ur.).
Zagreb, 2021. str. 42-42 (poster, međunarodna recenzija, sažetak, ostalo) -
33.Assessment of fatigue in cancer patients treated with ribociclib and endocrine therapy according to patient reported outcomes at the University hospital for tumors // Libri oncologici: 3th REGIONAL CONGRESS OF MEDICAL ONCOLOGY / Šeparović, Robert (ur.).
Zagreb, 2021. str. 40-40 (poster, međunarodna recenzija, sažetak, ostalo) -
34.The Role of Salivary and Serum Ca125 and Routine Blood Tests in Patients with Ovarian Malignancies // Acta clinica Croatica, 60 (2021), 1; 55-62 doi:10.20471/acc.2021.60.01.08 (međunarodna recenzija, članak, znanstveni)
-
35.Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients // Journal of oncology, 2021 (2021), 2815623, 8 doi:10.1155/2021/2815623 (međunarodna recenzija, članak, znanstveni)
-
36.Influence of Ile655Val polymorphism on trastuzumab‐induced cardiotoxicity in early‐stage HER2 positive breast cancer // Scientific reports, 11 (2021), 14395, 11 doi:10.1038/s41598-021-93634-6 (međunarodna recenzija, članak, znanstveni)
-
37.Utjecaj tjelesnog sastava na pojavnost neželjenih učinaka antineoplastičnih lijekova u bolesnica liječenih zbog ranog raka dojke, 2021., doktorska disertacija, Medicinski fakultet, Osijek
-
38.TDM-1 for HER2-Positive Advanced Breast Cancer – Clinical Practice Experience at University Hospital for Tumors // 14 hrvatski onkološki kongres 14th Croatian Oncology Congress / Eduard Vrdoljak, Marijana Jazvić (ur.).
Zagreb: Klinika za tumore, Klinički bolnički centar Sestre milosrdnice Ilica 197, 10 000 Zagreb, 2021. str. 128-129 (poster, domaća recenzija, sažetak, stručni) -
39.Preliminary Results of PIK3CA Mutation Analysis in Advanced Breast Cancer // 14 hrvatski onkološki kongres 14th Croatian Oncology Congress / Eduard Vrdoljak, Marijana Jazvić (ur.).
Zagreb: Klinika za tumore, Klinički bolnički centar Sestre milosrdnice Ilica 197, 10 000 Zagreb, 2021. str. 040-041 (poster, domaća recenzija, sažetak, znanstveni) -
40.Influence of Body Composition on Quality of Life (QoL) of Breast Cancer Patients Treated with Adjuvant Chemotherapy // 14 hrvatski onkološki kongres 14th Croatian Oncology Congress / Eduard Vrdoljak, Marijana Jazvić (ur.).
Zagreb: Klinika za tumore, Klinički bolnički centar Sestre milosrdnice Ilica 197, 10 000 Zagreb, 2021. str. 108-109 (poster, domaća recenzija, sažetak, znanstveni) -
41.Assessment of Alopecia in Cancer Patients Treated with CDK 4/6 Inhibitors and Antihormonal Therapy According to Patient Related Outcomes at the University Hospital for Tumors // 14 hrvatski onkološki kongres 14th Croatian Oncology Congress ; Virtual Congress / Eduard Vrdoljak, Marijana Jazvić (ur.).
Zagreb: Klinika za tumore, Klinički bolnički centar Sestre milosrdnice Ilica 197, 10 000 Zagreb, 2021. str. 85-85 (poster, domaća recenzija, sažetak, stručni) -
42.Clinical validity of compartmental analysis of tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) - the key is in spatial morphology? // Cancer Research ; San Antonio Breast Cancer Virtual Symposium ; Volume 81, Issue 4 Supplement
San Antonio (TX), Sjedinjene Američke Države ; online: American Association for Cancer Research, 2021. str. 56-56 doi:10.1158/1538-7445.SABCS20-PS6-56 (poster, međunarodna recenzija, sažetak, znanstveni) -
43.Oxaliplatin Induced Pulmonary Fibrosis: a Case Report // Acta clinica Croatica, 59 (2020), 4; 761-764 doi:10.20471/acc.2020.59.04.25 (međunarodna recenzija, članak, ostalo)
-
44.Overall survival (OS) results of patients with left-sided metastatic colorectal cancer (mCRC) in real life – experience from University Hospital for Tumors Zagreb, Croatia // Abstracts. U:Annals of Oncology 31(S3)
online, 2020. str. 147-148 doi:.org/10.1016/j.annonc.2020.04.259 (poster, međunarodna recenzija, sažetak, znanstveni) -
45.Pretilost i zloćudne bolesti // Pretilost i liječenje / Soldo, Ivo ; Kolak, Toni (ur.).
Zagreb: Medicinska naklada, 2020. str. 119-130 -
46.Prognostic value of tumor: Infiltrating lymphocytes and androgen receptors correlation in triple negative breast cancer. // Journal of Clinical Oncology 38, no. 15_suppl
Alexandria (VA): American Society of Clinical Oncology, 2020. doi:10.1200/JCO.2020.38.15_suppl.e12571 (poster, međunarodna recenzija, sažetak, znanstveni) -
47.Prognostic value of compartmental spatial analysis of tumour: Infiltrating lymphocytes in triple-negative breast cancer // Meeting Abstract. U: Annals of oncology 31(suppl.4)
Madrid, Španjolska, 2020. str. 285-285 doi:10.1016/j.annonc.2020.08.231 (poster, međunarodna recenzija, prošireni sažetak, ostalo) -
48.Characteristics and Prognosis of Triple- Negative Breast Cancer Patients: a Croatian Single Institution Retrospective Cohort Study // Acta Clinica Croatica, 59 (2020), 97-108 doi:10.20471/acc.2020.59.01.12 (međunarodna recenzija, članak, znanstveni)
-
49.Androgen receptors: unclear ubiquitious mechanism or the missing key in the triple– negative breast cancer? // Libri Oncologici Croatian Journal of Oncology, 48 (2020), 1; 20-26 doi:10.20471/lo.2020.48.01.04 (međunarodna recenzija, članak, znanstveni)
-
50.Phenotype variants of invasive breast cancer differ in associations between the primary tumor size and its Ki-67 value. // Journal of Clinical Oncology 2020 ; 38:15(suppl)
Alexandria (VA): American Society of Clinical Oncology, 2020. e12588, 1 doi:10.1200/JCO.2020.38.15_suppl.e12588 (ostalo, međunarodna recenzija, prošireni sažetak, znanstveni)
